Physician profile
Madison J Nutter
NPI 1922633957
$1,331.47
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $229 · 2022: $408 · 2023: $438 · 2024: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $518.55 | 2021-2024 | |
| Amgen INC. | $126.01 | 2021-2023 | Otezla, Repatha |
| Aimmune Therapeutics, INC. | $121.51 | 2024 | |
| Novo Nordisk INC | $93.86 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $55.75 | 2022-2024 | Zepbound, Mounjaro, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.30 | 2021-2022 | |
| Sanofi Pasteur INC. | $35.64 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $34.23 | 2022-2023 | Xarelto |
| Exact Sciences Corporation | $31.65 | 2023-2024 | Cologuard Collection Kit |
| Genentech USA, INC. | $30.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.52 | 2022-2023 | |
| Itamar Medical INC | $28.28 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.15 | 2023 | |
| Boston Scientific Corporation | $18.58 | 2023 | Watchman Access System |
| Philips North America LLC | $18.07 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.97 | 2021 | |
| Medtronic, INC. | $15.61 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.42 | 2021 | |
| Glaxosmithkline, LLC. | $13.48 | 2023 | Bexsero, Shingrix |
| Idorsia Pharmaceuticals US INC | $13.27 | 2022 | |
| Daiichi Sankyo INC. | $13.20 | 2021 | |
| Organon LLC | $12.95 | 2022 | |
| Mylan Specialty L.P. | $12.68 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Nutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.